Rituximab-induced progressive multifocal leucoencephalopathy (PML) in a patient treated for idiopathic thrombocytopenic purpura
Publisher
Radiopaedia.org
Reference4 articles.
1. Kelly D, Monaghan B, McMahon E, Watson G, Kavanagh E, O'Rourke K, McCaffrey J, Carney D. Progressive multifocal leukoencephalopathy secondary to rituximab-induced immunosuppression and the presence of John Cunningham virus: a case report and literature review. (2016) Radiology case reports. 11 (3): 251-4. 2. Clifford DB, Ances B, Costello C, Rosen-Schmidt S, Andersson M, Parks D, Perry A, Yerra R, Schmidt R, Alvarez E, Tyler KL. Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis. (2011) Archives of neurology. 68 (9): 1156-64. 3. Omri HE, Taha RY, Gamil A, Ibrahim F, Sabah HA, Mahmoud ZO, Pittari G, HIjji IA, Yassin MA. Efficacy and Safety of Rituximab for Refractory and Relapsing Thrombotic Thrombocytopenic Purpura: A Cohort of 10 Cases. (2015) Clinical medicine insights. Blood disorders. 8: 1-7. 4. Liang Y, Zhang L, Gao J, Hu D, Ai Y. Rituximab for children with immune thrombocytopenia: a systematic review. (2012) PloS one. 7 (5): e36698.
|
|